The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 23 May 2006, www.theannals.com, DOI 10.1345/aph.1G715.
The Annals of Pharmacotherapy: Vol. 40, No. 6, pp. 1082-1085. DOI 10.1345/aph.1G715
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Trissel, L. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Trissel, L. A

ONCOLOGY

Physical and Chemical Stability of Pemetrexed in Infusion Solutions

Yanping Zhang, BS

Research Investigator, MD Anderson Cancer Center, The University of Texas, Houston, TX

Lawrence A Trissel, BS FASHP

Director, Clinical Pharmaceutics Research, MD Anderson Cancer Center, The University of Texas

Reprints: Mr. Trissel, Division of Pharmacy, Unit 090, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Blvd., Houston, TX 77030-4095, fax 713/563-2958

BACKGROUND: Pemetrexed is a multitargeted, antifolate, antineoplastic agent that is indicated for single-agent use in locally advanced or metastatic non-small-cell lung cancer after prior chemotherapy and in combination with cisplatin for the treatment of malignant pleural mesothelioma not treatable by surgery. Currently, there is no information on the long-term stability of pemetrexed beyond 24 hours.

OBJECTIVE: To evaluate the longer-term physical and chemical stability of pemetrexed 2, 10, and 20 mg/mL in polyvinyl chloride (PVC) bags of dextrose 5% injection and NaCl 0.9% injection.

METHODS: Triplicate samples of pemetrexed were prepared in the concentrations and infusion solutions required. Evaluations for physical and chemical stability were performed initially and over 2 days at 23 °C protected from light and exposed to fluorescent light, and over 31 days of storage at 4°C protected from light. Physical stability was assessed using turbidimetric and particulate measurement as well as visual observation. Chemical stability was evaluated by HPLC.

RESULTS: All pemetrexed solutions remained chemically stable, with little or no loss of pemetrexed over 2 days at 23 °C, protected from light and exposed to fluorescent light, and over 31 days of storage at 4°C, protected from light. The room temperature samples were physically stable throughout the 48 hour test period. However, pemetrexed admixtures developed large numbers of microparticulates during refrigerated storage exceeding 24 hours.

CONCLUSIONS: Pemetrexed is chemically stable for 2 days at room temperature and 31 days refrigerated in dextrose 5% injection and NaCl 0.9% injection. However, substantial numbers of microparticulates may form in pemetrexed diluted in the infusion solutions in PVC bags, especially during longer periods of refrigerated storage. Limiting the refrigerated storage period to the manufacturer-recommended 24 hours will limit particulate formation.

Key Words: admixture, Alimta, pemetrexed, stability

Published Online, May 23, 2006. www.theannals.com, DOI 10.1345/aph.1G715





homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.